TORUS I Clinical Study

NAUnknownINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

March 31, 2016

Primary Completion Date

July 31, 2020

Study Completion Date

July 31, 2021

Conditions
Peripheral Arterial Disease
Interventions
DEVICE

PQ Bypass Stent Graft System

The PQ Bypass™ Stent Graft System is indicated to improve luminal diameter in the treatment of patients with symptomatic de novo or restenotic native lesions or occlusions of the superficial femoral artery (SFA) and/or proximal popliteal artery, with reference vessel diameters of 5.0 to 6.7 mm and lesion lengths up to 180 mm.

Sponsors

Lead Sponsor

All Listed Sponsors
lead

PQ Bypass, Inc.

INDUSTRY

NCT03128424 - TORUS I Clinical Study | Biotech Hunter | Biotech Hunter